Table 3.
Recorded symptoms and comorbidities characterizing the recruited individuals for each group.
| Emergency | Hospital Ward | ICU | Deceased | |||||
|---|---|---|---|---|---|---|---|---|
| M (77) | F (107) | M (105) | F (100) | M (14) | F (11) | M (23) | F (12) | |
| COVID-19 Symptoms | ||||||||
| Fever | 31 (40.26%) |
60 (56.07%) |
55 (52.38%) |
43 (43.00%) |
5 (35.71%) |
5 (45.45%) |
11 (47.83%) |
7 (58.33%) |
| Cough | 27 (35.06%) |
51 (47.66%) |
36 (34.29%) |
27 (27.00%) |
1 (7.14%) |
2 (18.18%) |
8 (34.78%) |
3 (25.00%) |
| Dyspnea | 14 (18.26%) |
30 (28.04%) |
42 (40.00%) |
31 (31.00%) |
2 (14.29%) |
6 (54.55%) |
15 (65.22%) |
9 (75.00%) |
| Asthenia | 10 (12.99%) |
23 (21.50%) |
8 (7.62%) |
12 (12.00%) |
0 (0.00%) |
3 (27.27%) |
3 (13.04%) |
2 (16.67%) |
| Rhinitis | 6 (7.89%) |
5 (4.67%) |
6 (5.61%) |
2 (2.00%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
1 (8.33%) |
| Memory deficits | 0 (0.00%) |
0 (0.00%) |
1 (0.95%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
1 (4.35%) |
1 (8.33%) |
| Vertigo | 2 (2.60%) |
3 (2.80%) |
0 (0.00%) |
4 (4.00%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
| Anosmia | 1 (1.30%) |
2 (1.87%) |
1 (0.95%) |
4 (4.00%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
1 (8.33%) |
| Ageusia | 1 (1.30%) |
2 (1.87%) |
1 (0.95%) |
2 (2.00%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
1 (8.33%) |
| Depression or anxiety | 3 (3.90%) |
2 (1.87%) |
1 (0.95%) |
4 (4.00%) |
1 (7.14%) |
0 (0.00%) |
0 (0.00%) |
1 (8.33%) |
| Brain fog | 1 (1.30%) |
0 (0.00%) |
1 (0.95%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
1 (4.35%) |
0 (0.00%) |
| Epistaxis | 0 (0.00%) |
0 (0.00%) |
1 (0.95%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
1 (8.33%) |
| Arthralgia or myalgia | 13 (16.88%) |
32 (29.91%) |
7 (6.67%) |
7 (7.00%) |
2 (14.29%) |
1 (9.09%) |
0 (0.00%) |
2 (16.67%) |
| Headache | 9 (11.69%) |
13 (12.15%) |
6 (5.71%) |
9 (9.00%) |
0 (0.00%) |
1 (9.09%) |
0 (0.00%) |
0 (0.00%) |
| Paresthesia | 3 (3.90%) |
0 (0.00%) |
0 (0.00%) |
2 (2.00%) |
1 (7.14%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
| Sore throat | 11 (14.29%) |
5 (4.67%) |
6 (5.71%) |
8 (8.00%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
| Comorbidities | ||||||||
| Lung diseases | 7 (9.09%) |
11 (10.28%) |
12 (11.43%) |
21 (21.00%) |
4 (28.57%) |
3 (27.27%) |
2 (8.70%) |
2 (16.67%) |
| Cardiac diseases | 15 (19.48%) |
23 (21.50%) |
54 (51.43%) |
54 54.00%) |
9 (64.29%) |
6 (54.55%) |
16 (69.57%) |
10 (83.33%) |
| Dyslipidemia | 3 (3.90%) |
2 (1.87%) |
11 (10.48%) |
9 (9.00%) |
2 (14.29%) |
0 (0.00%) |
0 (0.00%) |
1 (83.33%) |
| Chronic Renal Failure | 0 (0.00%) |
1 (0.93%) |
11 10.48%) |
11 (11.00%) |
2 (14.29%) |
1 (9.09%) |
6 (26.09%) |
2 (16.67%) |
| Oncological diseases | 3 (3.90%) |
12 (11.21%) |
13 (12.38%) |
15 (15.00%) |
1 (7.14%) |
2 (18.18%) |
9 (39.13%) |
3 (25.00%) |
| Diabetes | 2 (2.60%) |
2 (1.87%) |
19 (18.10%) |
18 (18.00%) |
3 (21.43%) |
2 (18.18%) |
2 (8.70%) |
3 (25.00%) |
| Gastrointestinal diseases | 9 (40.26%) |
9 (8.41%) |
11 (10.48%) |
10 (10.00%) |
4 (28.57%) |
2 (18.18%) |
4 (17.39%) |
3 (25.00%) |
| Neurological or psychiatric diseases | 6 (40.26%) |
4 (3.74%) |
14 (13.33%) |
22 (22.00%) |
3 (21.43%) |
5 (45.45%) |
8 (34.78%) |
3 (25.00%) |
| Urologic diseases | 5 (6.49%) |
5 (4.67%) |
9 (8.57%) |
3 (3.00%) |
3 (21.43%) |
1 (9.09%) |
6 (26.09%) |
0 (0.00%) |
| Ophthalmological diseases | 0 (0.00%) |
1 (0.93%) |
3 (2.86%) |
3 (3.00%) |
1 (7.14%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
| Immunological, rheumatological, or hematological diseases | 7 (9.09%) |
19 7.76%) |
16 (15.24%) |
25 (25.00%) |
1 (7.14%) |
0 (0.00%) |
4 (17.39%) |
2 (16.67%) |
| Ventilated patients | 0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
0 (0.00%) |
5 (21.74%) |
0 (0.00%) |